Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.860
+0.120 (6.90%)
At close: Nov 20, 2024, 4:00 PM
1.861
+0.001 (0.06%)
After-hours: Nov 20, 2024, 6:05 PM EST
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 47 employees as of December 31, 2023. The number of employees increased by 8 or 20.51% compared to the previous year.
Employees
47
Change (1Y)
8
Growth (1Y)
20.51%
Revenue / Employee
n/a
Profits / Employee
-$909,936
Market Cap
123.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Seres Therapeutics | 233 |
TELA Bio | 227 |
Rani Therapeutics Holdings | 140 |
Adlai Nortye | 127 |
InflaRx | 62 |
Elutia | 54 |
Journey Medical | 41 |
Fennec Pharmaceuticals | 29 |
MIST News
- 8 days ago - Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 2 months ago - Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewsWire
- 3 months ago - Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 5 months ago - Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024 - GlobeNewsWire
- 6 months ago - Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™ - GlobeNewsWire
- 6 months ago - Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire